MEETINGS - Conference on Regulation and Marketing for Self Diagnostic and Home Monitoring Products (UK) February 1998:
This article was originally published in Clinica
Executive Summary
Regulation and Marketing for Self Diagnostic & Home Monitoring Products is the subject of a conference to be held in London on February 12-13, 1998. Discussion topics include regulatory aspects of the self diagnostics market; the Internet - future sales route for diagnostics; and developments in genetic testing. For more information contact Elaine Rogers at the SMi UK office. Tel: +44 171 252 2222. Fax: +44 171 252 2272.
You may also be interested in...
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.